Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | prolylcarboxypeptidase (angiotensinase C) | Starlite/ChEMBL | References |
Homo sapiens | prolylcarboxypeptidase (angiotensinase C) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | serine carboxypeptidase S28, putative | prolylcarboxypeptidase (angiotensinase C) | 496 aa | 414 aa | 24.1 % |
Trypanosoma cruzi | serine carboxypeptidase S28, putative | prolylcarboxypeptidase (angiotensinase C) | 491 aa | 402 aa | 24.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Serine carboxypeptidase S28 family protein | 0.0225 | 0.0639 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0225 | 0.0639 | 1 |
Schistosoma mansoni | lysosomal Pro-Xaa carboxypeptidase (S28 family) | 0.0225 | 0.0639 | 0.0639 |
Toxoplasma gondii | cathepsin CPC2 | 0.1061 | 0.3684 | 0.3684 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.1061 | 0.3684 | 0.3684 |
Giardia lamblia | Encystation-specific protease | 0.1061 | 0.3684 | 0.3684 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.2796 | 1 | 1 |
Onchocerca volvulus | 0.0049 | 0 | 0.5 | |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.2796 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0425 | 0.1367 | 0.1367 |
Schistosoma mansoni | tyrosine kinase | 0.0435 | 0.1403 | 0.1403 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.2796 | 1 | 1 |
Trypanosoma cruzi | putative prolyl carboxypeptidase, putative | 0.0049 | 0 | 0.5 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.1061 | 0.3684 | 0.3684 |
Loa Loa (eye worm) | hypothetical protein | 0.0225 | 0.0639 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.2796 | 1 | 1 |
Echinococcus granulosus | Lysosomal Pro X carboxypeptidase | 0.0225 | 0.0639 | 0.4556 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.2796 | 1 | 1 |
Trypanosoma cruzi | serine carboxypeptidase S28, putative | 0.0049 | 0 | 0.5 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.2796 | 1 | 1 |
Trypanosoma cruzi | serine carboxypeptidase S28, putative | 0.0049 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.1735 | 0.6138 | 1 |
Entamoeba histolytica | serine carboxypeptidase (S28) family protein | 0.0049 | 0 | 0.5 |
Echinococcus multilocularis | Lysosomal Pro X carboxypeptidase | 0.0225 | 0.0639 | 0.4556 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.2796 | 1 | 1 |
Entamoeba histolytica | serine carboxypeptidase (S28) family protein | 0.0049 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0225 | 0.0639 | 1 |
Entamoeba histolytica | serine carboxypeptidase (S28) family protein | 0.0049 | 0 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase shark | 0.0435 | 0.1403 | 1 |
Echinococcus granulosus | tyrosine protein kinase shark | 0.0435 | 0.1403 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.6 nM | Inhibition of human PrCP | ChEMBL. | 22444683 |
IC50 (binding) | = 15 nM | Inhibition of mouse PrCP | ChEMBL. | 22444683 |
Ki (functional) | = 19.6 nM | Ex-vivo inhibition of po dosed mouse PrCP in the absence of plasma by FRET analysis | ChEMBL. | 22444683 |
Ratio Ki (functional) | = 8.4 | Plasma shift, ratio of Ki for PrCP in heat inactivated 100% plasma of po dosed mouse to Ki for po dosed mouse PrCP in the absence of plasma | ChEMBL. | 22444683 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 22444683 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.